Testing effectiveness (Phase 2)Ended earlyNCT02201524What this trial is testingStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Pfizer 59
Early research (Phase 1)UnknownNCT02918123What this trial is testingSafety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Kang Stem Biotech Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01901705What this trial is testingTopical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type PsoriasisWho this might be right forPsoriasis China Medical University Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00770965What this trial is testingPhase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT03131570What this trial is testingSafety and Efficacy of Secukinumab in Mild PsoriasisWho this might be right forPsoriasis James G. Krueger, MD, PhD 23
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Post-approval studies (Phase 4)Study completedNCT04571567What this trial is testingEvaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Saakshi Khattri 20
Large-scale testing (Phase 3)Study completedNCT00689481What this trial is testingStudy to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 StudiesWho this might be right forPsoriasis Stiefel, a GSK Company 323
Large-scale testing (Phase 3)Study completedNCT00747344What this trial is testingTrial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Centocor, Inc. 121
Large-scale testing (Phase 3)Study completedNCT02207244What this trial is testingGuselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentWho this might be right forPsoriasis Janssen Research & Development, LLC 992
Large-scale testing (Phase 3)Study completedNCT03066609What this trial is testingStudy of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT00759161What this trial is testingSafety and Efficacy Study of A Novel Ointment to Treat Plaque Type PsoriasisWho this might be right forPsoriasis Pfizer 35
Testing effectiveness (Phase 2)Study completedNCT04911751What this trial is testingInvestigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type PsoriasisWho this might be right forPsoriatic Plaque KoBioLabs 80
Large-scale testing (Phase 3)UnknownNCT01628081What this trial is testingThe Effect of Alga Dunaliella Bardawil on PsoriasisWho this might be right forPsoriasis Sheba Medical Center 46
Large-scale testing (Phase 3)Study completedNCT04930042What this trial is testingEfficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Alvotech Swiss AG 581
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854What this trial is testingA Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Dermavon Holdings Limited 540
Early research (Phase 1)Study completedNCT03399526What this trial is testing1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratWho this might be right forPsoriasis Bayer 24
Testing effectiveness (Phase 2)Study completedNCT00885196What this trial is testingA Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisWho this might be right forModerate and Severe Plaque Psoriasis Novartis Pharmaceuticals 336
Large-scale testing (Phase 3)WithdrawnNCT01121081What this trial is testingThe Effect of Algae Dunaliella Bardawil on Psoriasis (2)Who this might be right forPsoriasis Sheba Medical Center
Not applicableStudy completedNCT02274363What this trial is testingAssess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type PsoriasisWho this might be right forPsoriasisPlaque Janssen Pharmaceutica 1,131